by mroseboro | Jan 20, 2021 | Featured News |
FEATURED NEWS 2021 > January January 20, 2021 | Turnstone Biologics Acquires Novel Cell Therapy Platform Acquisition of Myst Therapeutics adds proprietary tumor infiltrating lymphocyte (“TIL”) technology and programs to Turnstone’s growing portfolio NEW YORK...
by mroseboro | May 4, 2020 | Entrepreneurship, Featured News, Incubator, News, Pharmaceutical |
FEATURED NEWS May 4, 2020 | Myst Therapeutics Appoints George Smith as Vice President of Business Operations LOS ANGELES – (BUSINESS WIRE) – Myst Therapeutics (Myst), a preclinical stage biotechnology company focused on developing selected TIL-based...
Recent Comments